Insider · CIK 0001709772

Bergstrom Donald A

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001709772

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-08	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−8,530 sh	$18.97	−$162K	399,130
2026-07-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−2,237 sh	$18.61	−$41.6K	407,660
2026-07-06	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−8,660 sh	$18.71	−$162K	409,897
2026-06-22	RLAYRelay Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+93.5K sh	$4.12	+$385K	512,013
2026-06-22	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−93.5K sh	$16.94	−$1.58M	418,557
2026-06-22	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−93.5K sh	—	—	0
2026-04-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−1,490 sh	$14.79	−$22K	418,557
2026-01-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−2,686 sh	$8.45	−$22.7K	420,047
2026-01-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−18.9K sh	$7.62	−$144K	422,733
2026-01-13	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	President, R&D	AAward	+575K sh	—	—	575,000
2025-10-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−30.9K sh	$7.29	−$225K	521,823
2025-07-29	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−26.7K sh	$3.68	−$98.3K	552,720
2025-07-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−4,069 sh	$3.74	−$15.2K	579,421
2025-04-30	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−27.5K sh	$3.00	−$82.4K	583,490
2025-04-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−4,090 sh	$3.17	−$13K	610,962
2025-03-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−986 sh	$2.84	−$2,800.24	615,052
2025-01-30	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−30.8K sh	$4.42	−$136K	616,038
2025-01-29	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−46.4K sh	$4.55	−$211K	646,861
2025-01-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−3,220 sh	$4.63	−$14.9K	516,868
2025-01-28	RLAYRelay Therapeutics, Inc.A Award	President, R&D	AAward	+176K sh	—	—	693,268
2025-01-10	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	President, R&D	AAward	+400K sh	—	—	400,000
2024-12-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−657 sh	$4.38	−$2,877.66	520,088
2024-10-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−2,688 sh	$6.06	−$16.3K	520,745
2024-09-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−648 sh	$7.51	−$4,866.48	523,433
2024-07-29	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−2,698 sh	$8.85	−$23.9K	524,081
2024-06-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−648 sh	$6.26	−$4,056.48	526,779
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−34K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2024-04-29	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−2,686 sh	$6.38	−$17.1K	527,427
2024-03-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−765 sh	$7.70	−$5,890.5	530,113
2024-01-29	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−3,178 sh	$9.64	−$30.6K	530,878
2024-01-16	RLAYRelay Therapeutics, Inc.A Award	President, R&D	AAward	+300K sh	—	—	534,056
2023-12-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−977 sh	$11.51	−$11.2K	234,056
2023-10-30	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−3,451 sh	$6.03	−$20.8K	235,033
2023-09-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−648 sh	$8.38	−$5,430.24	238,484
2023-07-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−2,683 sh	$11.80	−$31.7K	237,904
2023-06-30	RLAYRelay Therapeutics, Inc.A Award	President, R&D	AAward	+1,228 sh	$10.68	+$13.1K	241,815
2023-06-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−647 sh	$12.12	−$7,841.64	240,587
2023-06-14	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2023-04-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−2,850 sh	$11.16	−$31.8K	241,234
2023-04-28	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−1,383 sh	$11.16	−$15.4K	242,701
2023-03-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−763 sh	$15.36	−$11.7K	244,084
2023-01-30	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−1,429 sh	$21.56	−$30.8K	244,847
2023-01-17	RLAYRelay Therapeutics, Inc.A Award	President, R&D	AAward	+160K sh	—	—	246,276
2023-01-17	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	President, R&D	AAward	+160K sh	—	—	160,390
2023-01-17	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	President, R&D	AAward	+160K sh	—	—	160,390
2022-12-27	RLAYRelay Therapeutics, Inc.S Sale	President, R&D	SSale	−980 sh	$14.49	−$14.2K	85,886
2022-11-01	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−8,000 sh	—	—	93,456

Recent filings

Accepted (ET)
Sep 94
Bergstrom Donald A0001193125-26-386473
SEC(opens sec.gov)
Jul 304
Bergstrom Donald A0001193125-26-326137
SEC(opens sec.gov)
Jul 84
Bergstrom Donald A0001193125-26-298688
SEC(opens sec.gov)
Jun 244
Bergstrom Donald A0001193125-26-281059
SEC(opens sec.gov)
Apr 304
Bergstrom Donald A0001193125-26-197395
SEC(opens sec.gov)
Jan 294
Bergstrom Donald A0001193125-26-029415
SEC(opens sec.gov)
Jan 154
Bergstrom Donald A0001193125-26-014111
SEC(opens sec.gov)
Oct 304
Bergstrom Donald A0001193125-25-258557
SEC(opens sec.gov)
Jul 304
Bergstrom Donald A0000950170-25-100365
SEC(opens sec.gov)
Apr 304
Bergstrom Donald A0000950170-25-061365
SEC(opens sec.gov)
Mar 314
Bergstrom Donald A0000950170-25-047762
SEC(opens sec.gov)
Jan 304
Bergstrom Donald A0000950170-25-011319
SEC(opens sec.gov)

Companies

Address

C/O RELAY THERAPEUTICS, INC. 60 HAMPSHIRE STREET

CAMBRIDGE, MA, 02139